Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 1
1991 1
1995 1
1996 1
1997 1
1998 3
1999 1
2000 4
2001 7
2002 2
2003 7
2004 6
2005 5
2006 6
2007 13
2008 7
2009 6
2010 9
2011 11
2012 15
2013 21
2014 18
2015 13
2016 4
2017 6
2018 4
2019 13
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

185 results
Results by year
Filters applied: . Clear all
Page 1
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics.
De Groot AS, Terry F, Cousens L, Martin W. De Groot AS, et al. Expert Rev Clin Pharmacol. 2013 Nov;6(6):651-62. doi: 10.1586/17512433.2013.835698. Expert Rev Clin Pharmacol. 2013. PMID: 24164613 Free PMC article. Review.
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation.
Jawa V, Cousens LP, Awwad M, Wakshull E, Kropshofer H, De Groot AS. Jawa V, et al. Among authors: de groot as. Clin Immunol. 2013 Dec;149(3):534-55. doi: 10.1016/j.clim.2013.09.006. Epub 2013 Sep 25. Clin Immunol. 2013. PMID: 24263283 Free article. Review.
Highly conserved influenza T cell epitopes induce broadly protective immunity.
Eickhoff CS, Terry FE, Peng L, Meza KA, Sakala IG, Van Aartsen D, Moise L, Martin WD, Schriewer J, Buller RM, De Groot AS, Hoft DF. Eickhoff CS, et al. Among authors: de groot as. Vaccine. 2019 Aug 23;37(36):5371-5381. doi: 10.1016/j.vaccine.2019.07.033. Epub 2019 Jul 19. Vaccine. 2019. PMID: 31331771 Free PMC article.
Publisher Correction: A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines.
Wada Y, Nithichanon A, Nobusawa E, Moise L, Martin WD, Yamamoto N, Terahara K, Hagiwara H, Odagiri T, Tashiro M, Lertmemongkolchai G, Takeyama H, De Groot AS, Ato M, Takahashi Y. Wada Y, et al. Among authors: de groot as. Sci Rep. 2019 Oct 8;9(1):14730. doi: 10.1038/s41598-019-50828-3. Sci Rep. 2019. PMID: 31594990 Free PMC article.
Agility in adversity: Vaccines on Demand.
De Groot AS, Moise L, Olive D, Einck L, Martin W. De Groot AS, et al. Expert Rev Vaccines. 2016 Sep;15(9):1087-91. doi: 10.1080/14760584.2016.1205951. Epub 2016 Jul 18. Expert Rev Vaccines. 2016. PMID: 27389971 Review.
Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction.
De Groot AS, Skowron G, White JR, Boyle C, Richard G, Serreze D, Martin WD. De Groot AS, et al. Sci Rep. 2019 Nov 6;9(1):16103. doi: 10.1038/s41598-019-52331-1. Sci Rep. 2019. PMID: 31695065 Free PMC article.
Fifth Vaccine Renaissance introduction.
De Groot AS. De Groot AS. Hum Vaccin Immunother. 2012 Jul;8(7):960. doi: 10.4161/hv.21442. Epub 2012 Jul 1. Hum Vaccin Immunother. 2012. PMID: 22832257 Free PMC article. No abstract available.
Differential functional patterns of memory CD4+ and CD8+ T-cells from volunteers immunized with Ty21a typhoid vaccine observed using a recombinant Escherichia coli system expressing S. Typhi proteins.
Salerno-Gonçalves R, Tettelin H, Luo D, Guo Q, Ardito MT, Martin WD, De Groot AS, Sztein MB. Salerno-Gonçalves R, et al. Among authors: de groot as. Vaccine. 2020 Jan 10;38(2):258-270. doi: 10.1016/j.vaccine.2019.10.020. Epub 2019 Oct 16. Vaccine. 2020. PMID: 31629569
Vaccine informatics.
He Y, Rappuoli R, De Groot AS, Chen RT. He Y, et al. Among authors: de groot as. J Biomed Biotechnol. 2010;2010:765762. doi: 10.1155/2010/765762. Epub 2011 Jun 22. J Biomed Biotechnol. 2010. PMID: 21772788 Free PMC article. No abstract available.
Computational vaccinology and the ICoVax 2012 workshop.
He Y, Cao Z, De Groot AS, Brusic V, Schönbach C, Petrovsky N. He Y, et al. Among authors: de groot as. BMC Bioinformatics. 2013;14 Suppl 4(Suppl 4):I1. doi: 10.1186/1471-2105-14-S4-I1. Epub 2013 Mar 8. BMC Bioinformatics. 2013. PMID: 23514034 Free PMC article.
185 results
Jump to page